Vorhersage der Wirksamkeit einer Androgendeprivationstherapie bei Prostatakrebs

Details

Veröffentlichungs-Nr.

EP4752233

Anmeldetag

28. November 2024

Veröffentlichung

3. Juni 2026

Rechtsraum

EP

IPC

(HOFFMANN RALF DIETER et al.)(MITROFANOVA ANTONINA et al.)

Abstract

The invention relates to methods for predicting an outcome for a prostate cancer patient. In particular the method describes a model based on the expression levels of marker genes which can be used to predict the effectiveness of androgen deprivation therapy (ADT). The method allows for treatment suggestions, particularly for those patients where ADT is predicted not to be effective, and alternative treatment may be desirable. The invention further describes kits useful for use in the described methods, as well as composition for use in treatment of prostate cancer based on a treatment outcome prediction described herein.

Anmelder

Firma

Koninklijke Philips N.V.

Land

🇳🇱 Niederlande